Ethical and Regulatory Considerations in Neuropharmacology

This track invites submissions that explore the ethical and regulatory challenges associated with neuropharmacology research and drug development. Researchers should focus on issues such as informed consent, patient safety, and the approval process for new therapies. The track will cover both the ethical implications of emerging technologies, such as gene editing and AI, and the regulatory landscape for neuropharmacology. Attendees will gain insights into the complexities of navigating the ethical and regulatory environment in neuropharmacology, and the importance of balancing innovation with patient protection.

    Related Conference of Ethical and Regulatory Considerations in Neuropharmacology

    March 17-18, 2025

    9th Global Summit onNephrology, Urology and Kidney Transplantation

    Singapore City, Singapore
    March 24-25, 2025

    21st World Nephrology Conference

    Amsterdam, Netherlands
    May 26-27, 2025

    29th European Nephrology Conference

    Rome, Italy
    June 23-24, 2025

    14th International Conference on Nephrology & Therapeutics

    Aix-en-Provence, France

    Ethical and Regulatory Considerations in Neuropharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in